Press Releases

GI Dynamics to Present at Upcoming Investor Conferences

Lexington, Massachusetts, United States and Sydney, Australia – 6 November 2012 – GI Dynamics, Inc. (ASX: GID), a company pioneering the development of effective, non-surgical approaches for treating type 2 diabetes and obesity, announced today that Stuart A. Randle, president and chief executive...

read more

Study Presented at American Society for Metabolic & Bariatric Surgery Meeting Demonstrates Efficacy of EndoBarrier® Therapy in Treating Overweight and Mildly Obese Type 2 Diabetes Patients

Lexington, Mass., United States and Sydney, Australia – June 22, 2012 – GI Dynamics, Inc. (ASX: GID) announced today that clinical data about EndoBarrier® Therapy, a breakthrough treatment for type 2 diabetes and/or obesity, was presented at the 29th Annual Meeting of the American Society for...

read more
Page 14 of 19« First...1213141516...Last »